Sabby Management’s Assembly Biosciences ASMB Stock Holding History

Sabby Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3	Closed	-$61K	–	239
2013 Q4	$61K	Buy	+3	New	+$546	﹤0.01%	206

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management's ASMB Position: Q4 2016 in Review

Sabby Management sold out of Assembly Biosciences (ASMB) in Q4 2016, closing a stake of 6,267 shares — an estimated $542K sold.

Sabby Management first reported a position in ASMB in Q2 2013 and held it in 3 quarters. The position peaked at $1.67M in Q2 2013. 36 funds tracked by Wall St. Rank hold ASMB as of Q4 2016.

Sabby Management reported no remaining Assembly Biosciences position as of Q4 2016 after selling out during the quarter.
Sabby Management sold 6,267 Assembly Biosciences shares in Q4 2016, an estimated $542K.
Sabby Management first reported a position in Assembly Biosciences in Q2 2013 and held it in 3 quarters.
Sabby Management's Assembly Biosciences position peaked at $1.67M in Q2 2013.
36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.